Documentation scienceplus.abes.fr version Bêta

À propos de : Treatment of acute malaria with a synthetic alkaloid of the quinazolone series (1698L)        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Treatment of acute malaria with a synthetic alkaloid of the quinazolone series (1698L)
has manifestation of work
related by
Author
Abstract
  • Abstract. (1) (1)Antimalarial compound 1698L, a synthetic alkaloid of the quinazolone series, was tested in Malaya in Asians with naturally occurring light infections of P. falciparum and P. vivax. (2) (2)Doses of 1 to 4 mg. daily for 5 to 7 days proved almost useless as a treatment for 10 patients with acute falciparum malaria. Falciparum gametocytes seemed unaffected. (3) (3)The acute attack was apparently cured in four out of six patients with vivax malaria given doses of 2 to 4 mg. daily for 4 to 7 days. (4) (4)The drug had a pronounced emetic action ; nine out of fourteen patients on doses of 2 to 4 mg. daily suffered from nausea and frequent vomiting. (5) (5)For the present, this compound remains of mainly theoretical interest.
article type
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata